China · Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 15.25 billion. The enterprise value is 13.71 billion.
| Market Cap | 15.25B |
| Enterprise Value | 13.71B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has increased by 1.71% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | +1.71% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 50.93% |
| Owned by Institutions (%) | 7.96% |
| Float | 374.61M |
Valuation Ratios
The trailing PE ratio is 23.43 and the forward PE ratio is 24.16.
| PE Ratio | 23.43 |
| Forward PE | 24.16 |
| PS Ratio | 7.38 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 4.30 |
| P/FCF Ratio | 21.54 |
| P/OCF Ratio | 17.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.59, with an EV/FCF ratio of 19.36.
| EV / Earnings | 20.95 |
| EV / Sales | 6.63 |
| EV / EBITDA | 14.59 |
| EV / EBIT | 16.61 |
| EV / FCF | 19.36 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.21 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.38 |
| Debt / FCF | 1.84 |
| Interest Coverage | 16.20 |
Financial Efficiency
Return on equity (ROE) is 18.53% and return on invested capital (ROIC) is 31.23%.
| Return on Equity (ROE) | 18.53% |
| Return on Assets (ROA) | 9.34% |
| Return on Invested Capital (ROIC) | 31.23% |
| Return on Capital Employed (ROCE) | 20.33% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | 898,021 |
| Profits Per Employee | 284,330 |
| Employee Count | 2,200 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, SHE:300529 has paid 127.39 million in taxes.
| Income Tax | 127.39M |
| Effective Tax Rate | 16.26% |
Stock Price Statistics
The stock price has decreased by -5.34% in the last 52 weeks. The beta is 0.28, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -5.34% |
| 50-Day Moving Average | 16.24 |
| 200-Day Moving Average | 17.59 |
| Relative Strength Index (RSI) | 68.58 |
| Average Volume (20 Days) | 13,409,733 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 2.07 billion and earned 654.24 million in profits. Earnings per share was 0.84.
| Revenue | 2.07B |
| Gross Profit | 1.60B |
| Operating Income | 824.96M |
| Pretax Income | 783.35M |
| Net Income | 654.24M |
| EBITDA | 937.06M |
| EBIT | 824.96M |
| Earnings Per Share (EPS) | 0.84 |
Balance Sheet
The company has 2.84 billion in cash and 1.30 billion in debt, with a net cash position of 1.54 billion or 1.99 per share.
| Cash & Cash Equivalents | 2.84B |
| Total Debt | 1.30B |
| Net Cash | 1.54B |
| Net Cash Per Share | 1.99 |
| Equity (Book Value) | 3.65B |
| Book Value Per Share | 4.72 |
| Working Capital | 1.75B |
Cash Flow
In the last 12 months, operating cash flow was 887.14 million and capital expenditures -179.27 million, giving a free cash flow of 707.88 million.
| Operating Cash Flow | 887.14M |
| Capital Expenditures | -179.27M |
| Depreciation & Amortization | 112.10M |
| Net Borrowing | -165.16M |
| Free Cash Flow | 707.88M |
| FCF Per Share | 0.91 |
Margins
Gross margin is 77.43%, with operating and profit margins of 39.92% and 31.66%.
| Gross Margin | 77.43% |
| Operating Margin | 39.92% |
| Pretax Margin | 37.91% |
| Profit Margin | 31.66% |
| EBITDA Margin | 45.35% |
| EBIT Margin | 39.92% |
| FCF Margin | 34.26% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 2.64%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 2.64% |
| Dividend Growth (YoY) | -35.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 65.25% |
| FCF Payout Ratio | 56.88% |
| Buyback Yield | -1.71% |
| Shareholder Yield | 0.93% |
| Earnings Yield | 4.27% |
| FCF Yield | 4.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for SHE:300529 is 24.12, which is 22.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24.12 |
| Price Target Difference | 22.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 7.87% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 6.64 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.64 |
| Piotroski F-Score | 6 |